Clinical Trials Browser

Colonic Neoplasms, Neoplasm Metastasis, Colorectal Neoplasms

Colonic Neoplasms

Carcinoma, Hepatocellular

Colonic Neoplasms, Rectal Neoplasms, Colorectal Neoplasms

Carcinoma, Hepatocellular

Stomach Neoplasms

Colorectal Neoplasms

Colorectal Neoplasms

Adenocarcinoma Of Esophagus

Colorectal Adenocarcinoma

Rectal Neoplasms

Neoplasm Metastasis, Stomach Neoplasms

Rectal Neoplasms

Pancreatic cancer, adult

Stomach Neoplasms

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Colorectal Neoplasms

Colonic Neoplasms

Pancreatic Cyst, Pancreatic Neoplasms

Colorectal Neoplasms

Rectal Neoplasms

Carcinoma, Hepatocellular

Colorectal Neoplasms

Carcinoma, Hepatocellular

Colonic Neoplasms

Rectal Neoplasms

Colonic Neoplasms

Pancreatic Neoplasms

Esophageal Neoplasms

Colorectal Neoplasms

Colorectal Neoplasms

Colonic Neoplasms, Lung Neoplasms, Prostatic Neoplasms

Rectal Neoplasms

Pancreatic Neoplasms

Carcinoma, Hepatocellular

Psychological Well-Being, Esophageal Neoplasms, Lung Neoplasms, Motor Activity, Stomach Neoplasms

Esophageal Squamous Cell Carcinoma

Hyperthermia, Rectal Neoplasms

Stomach Neoplasms

Neoplasms, Stomach Neoplasms

Colorectal Neoplasms

Digestive System Diseases, Gastrointestinal Diseases, Gastrointestinal Neoplasms, Colorectal Neoplasms

Esophageal Neoplasms

Esophageal Neoplasms

Carcinoma, Hepatocellular

Rectal Neoplasms

Clinical Stage I Esophageal Adenocarcinoma AJCC v8

PDAC - Pancreatic Ductal Adenocarcinoma

Stomach Neoplasms

Rectal Neoplasms

Esophageal Neoplasms

Clinical Trials

COLOCROSS

Neoadjuvant Chemotherapy Versus Standard Treatment in Patients With Locally Advanced Colon Cancer

Effects of Neoadjuvant Immunotherapy on Anti-tumour Immunity in Hepatocellular Carcinoma Patients Undergoing Liver Resection

00-046

REPLACE

Laparoscopic Gastrectomy With D2 Lymphadenectomy Combined With Hyperthermic Intraperitoneal Chemotherapy (HIPEC) or Not

TRIBE-C

Testing the Addition of Total Ablative Therapy to Usual Systemic Therapy Treatment for Limited Metastatic Colorectal Cancer, The ERASur Study

mFOLFIRINOX Versus mFOLFOX With or Without Nivolumab for the Treatment of Advanced, Unresectable, or Metastatic HER2 Negative Esophageal, Gastroesophageal Junction, and Gastric Adenocarcinoma

SOLARIS

FOBEAR

CIME

Short-Course Radiotherapy Followed by Neoadjuvant Chemotherapy and Camrelizumab in Locally Advanced Rectal Cancer (UNION)

Surufatinib Plus Gemcitabine and Nab-paclitaxel vs. Gemcitabine Plus Nab-paclitaxel in Neoadjuvant Therapy for High - Risk Resectable or Borderline Resectable Pancreatic Cancer

KLASS-09

Self-Management Survivorship Care in Stage I-III Non-small Cell Lung Cancer or Colorectal Cancer

DIAMOND

Is Intraperitoneal Drainage Necessary Following Distal Pancreatectomy?

ASPIK French

RECTIL

Adjuvant TACE in HCC With High-risk Recurrence Factors

Combination With Sintilimab and XELOX+Bevacizumab as 1st Line Therapy in RAS-mutant Metastatic Colorectal Cancer

Radiation Therapy With Protons or Photons in Treating Patients With Liver Cancer

ECTX

A Clinical Trial Comparing Long-Course Versus Short-Course Radiotherapy Followed by Immunotherapy Combined With Total Neoadjuvant Therapy (TNT) to Long-Course Radiotherapy Followed by TNT in High-Risk Locally Advanced Rectal Cancer

Neoadjuvant FOLFOX Chemotherapy for Patients With Locally Advanced Colon Cancer

Testing the Use of the Usual Chemotherapy Before and After Surgery for Removable Pancreatic Cancer

CCRT Followed by PD-1 Inhibitor Maintenance Therapy in Locally Advanced ESCC

INCISIVE

IRIMAD

ID-COMET

Preoperative FOLFOX Versus Postoperative Risk-adapted Chemotherapy in Patients With Locally Advanced Rectal Cancer

LAP100

SBRT Versus Surgical Resection for Small HCC

POISE

TD-NEOE3V3

mEHT

XELOX for 4 Months Versus 6 Months in Gastric Cancer (LOMAC)

Adjuvant Oxaliplatin Plus S-1 Versus Docetaxel Plus S-1 for Stage III Gastric Cancer

Fruquintinib Versus Bevacizumab Plus Chemotherapy in Second-Line RAS-Mutant Metastatic Colorectal Cancer (FRU-RAS)

ALTAIR

Chemoradiotherapy in Esophageal or Esophagogastric Junction Cancer

Neoadjuvant Treatment Modalities in Esophageal Cancer

Camrelizumab, Apatinib Plus HAIC Versus Camrelizumab and Apatinib for HCC With Portal Vein Invasion: a Randomized Trial

NORAD01

Comparing Proton Therapy to Photon Radiation Therapy for Esophageal Cancer

A Phase III, Randomized, Clinical Trial of GnP Combined With SBRT and Serplulimab Versus GnP as First-Line Treatment for Patients With Recurrent or Metastatic Pancreatic Cancer (WGOG-PAN 006/ICSBR-2)

Robotic vs Laparoscopic Gastrectomy for cT4a Gastric Cancer

WW3

TDLN-sparing RT Plus Immunotherapy and Chemotherapy in Locally Advanced ESCC